...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Embargo
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Just found it in bold type on the meeting home page.

"The full text of the clinical trial and late-breaking abstracts will not be posted until 4:30 p.m. ET on Friday, March 31."

3 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply